The Bodyfat GuideLose fat, keep muscle
GLP-1 drugs

Do GLP-1 drugs make you lose muscle?

By GyroscopeUpdated November 10, 20264 sources
On this page
  1. The numbers from the trials
  2. Why it happens
  3. What to do

Some, the way any large weight loss does. In the tirzepatide trial’s scan study, about a quarter of the weight people lost was lean mass, the same share as in the placebo group, who lost weight on diet and exercise advice. The drugs cause more loss, so more lean mass goes in pounds. Lifting and protein are how you keep it.

The numbers from the trials

Drug, trialPeople scannedFat lostLean mass lostLean share of the loss
Tirzepatide, SURMOUNT-116033.9% of their fat10.9% of their lean massabout 26% (placebo 25%)
Semaglutide, STEP 114019.3% of their fat9.7% of their lean massabout 38 to 40%

Lean mass counts everything that isn’t fat or bone, including water, organs and skin, so muscle is only part of it. The 2025 nutrition advisory from four US societies makes the same point.

There’s a hopeful sign too. In SEMALEAN, a year-long study of 106 adults with severe obesity on semaglutide, lean mass fell about 7 pounds (3 kg) by month seven and then held steady, while hand grip strength rose by about 9 pounds (4 kg).

Why it happens

Eating far less means less protein and less fuel coming in, and muscle that isn’t being worked hard is the tissue the body lets go. Lifting on a GLP-1 is like putting a keep sticker on your muscle before the movers arrive.

What to do

  • Lift at least two or three days a week. The 2025 advisory suggests strength training at least three times a week, plus at least 150 minutes of moderate cardio.
  • Eat your protein first at each meal. The advisory suggests about 1.5 g per kg of lean mass, or 80 to 120 grams a day. Under 1.2 g per kg of body weight is too low for most people. Find your range.
  • Track strength and waist, not just the scale.
  • Talk with your prescriber if you can’t eat enough or you’re losing fast. Never change a dose on your own.

The drug pages have the trial details: Ozempic and Wegovy, Mounjaro and Zepbound.

4 sources
  1. Look et al., Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight, Diabetes, Obesity and Metabolism, 2025pmc.ncbi.nlm.nih.gov
  2. Wilding et al., Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study, Journal of the Endocrine Society, 2021pmc.ncbi.nlm.nih.gov
  3. Mozaffarian et al., Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, American Journal of Clinical Nutrition, 2025pmc.ncbi.nlm.nih.gov
  4. Alissou et al., Impact of semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study, Diabetes, Obesity and Metabolism, 2026pmc.ncbi.nlm.nih.gov
Weigh in each morning on a Withings or any Apple Health scale and Gyroscope logs your weight and bodyfat on its own, free on any plan. Open Gyroscope

Your personalized guide

Get your own fat loss plan

Your calories to lose, the date you get there, your protein and the three habits to start with.

  • Personalized for you
  • Your calories and your date
  • Free, in about two minutes
Start